When the pharmaceutical industry started to research vaccines to fight COVID-19 in the spring of 2020, the concern that global manufacturing and packaging capacities would need to be increased arose almost simultaneously. At Catalent Pharma Solutions, a leading development and manufacturing partner to pharmaceutical companies, preparations began to boost vaccine production capabilities.

CSPE reduces the time span between designing the system and the start of production. After numerous turnkey projects involving the use of the turbo booster, Gerhard Breu, Chairman of the Optima Pharma Division, takes stock and gives an insight into how CSPE will become even more effective in the future.